| Gene symbol | CD70 | Synonyms | CD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.3 | dbXrefs | |
| Description | CD70 molecule | ||||
| GTO ID | GTC2559 |
| Trial ID | NCT04696731 |
| Disease | Clear Cell Renal Cell Carcinoma |
| Altered gene | CD70 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ALLO-316 |
| Co-treatment | ALLO-647 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma |
| Year | 2021 |
| Country | United States |
| Company sponsor | Allogene Therapeutics |
| Other ID(s) | ALLO-316-101 |
| Cohort 1 | |||||||||||
|
|||||||||||